You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.

Category:

BCRF News x

A BCRF researcher for two decades, Dr. Wigler shares his pioneering work in molecular biology.
BCRF investigator Kent Osborne discusses the successes, challenges and opportunities in treatment for HER2-positive breast cancer.
BCRF researcher Dr. Charles Perou has helped categorize TNBC tumors into 4 distinct molecular subtypes.
BCRF investigators Fabrice André, Sarat Chandalapaty, and Nikhil Wagle address the challenges of resistance to CDK4/6 inhibitors.
Tags:
On Triple Negative Breast Cancer Awareness Day, we highlight new treatments for this aggressive disease.